Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1978 4
1979 2
1980 4
1981 1
1982 1
1983 4
1984 1
1985 5
1986 6
1987 3
1988 2
1989 8
1991 4
1992 4
1993 2
1994 4
1995 3
1996 1
1997 5
1998 2
1999 8
2000 9
2001 10
2002 4
2003 4
2004 9
2005 9
2006 4
2007 10
2008 14
2009 12
2010 16
2011 17
2012 8
2013 11
2014 11
2015 11
2016 10
2017 13
2018 15
2019 8
2020 7
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

259 results
Results by year
Filters applied: . Clear all
Page 1
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D; ASCEND investigators. Kapoor R, et al. Lancet Neurol. 2018 May;17(5):405-415. doi: 10.1016/S1474-4422(18)30069-3. Epub 2018 Mar 12. Lancet Neurol. 2018. PMID: 29545067 Clinical Trial.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators. Coles AJ, et al. Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1. Lancet. 2012. PMID: 23122650 Clinical Trial.
Pain and MS.
Solaro C, Lunardi GL, Mancardi GL. Solaro C, et al. Among authors: mancardi gl. Int MS J. 2003 Apr;10(1):14-9. Int MS J. 2003. PMID: 12906765 Review.
Molecular basis of inherited neuropathies.
Schenone A, Mancardi GL. Schenone A, et al. Among authors: mancardi gl. Curr Opin Neurol. 1999 Oct;12(5):603-16. doi: 10.1097/00019052-199910000-00015. Curr Opin Neurol. 1999. PMID: 10590898 Review.
259 results